Fei Y, Tsoi MF, Cheung BMY
This dual action of increasing insulin while decreasing glucagon creates a more balanced and effective approach to blood sugar control
doi: 10.18433/J3CC86 Summary Keywords type 2 diabetes mellitus, glucagon-like peptide-1 receptor agonists, gastrointestinal side effects, risk factors, nomogram Citation Gao R, Li Y, Li A, Zhou P, Zong H and Li Y (2024) Risk factor screening and prediction modeling of gastrointestinal adverse reactions caused by GLP-1RAs
Quick Answer: Dulaglutide and once-weekly exenatide appear to have the lowest rates of nausea amongst GLP-1 receptor agonists, with approximately 1224% of patients affected compared with higher rates seen with other formulations
Use the Melanotan Express coupon right now for amazing savings on your items